Vaping exposes you to far fewer toxicants than smoking cigarettes, but that does not make it safe. Exclusive e-cigarette users carry roughly 10% to 98% lower concentrations of cancer-linked chemicals in their bodies compared with smokers, yet they still inhale aldehydes, heavy metals, and ultrafine particles that damage cells in ways researchers are only now beginning to catalog. The picture that has emerged over the past few years is not a simple thumbs-up or thumbs-down. It depends heavily on what you are comparing vaping to, how you vape, what device you use, and whether you were smoking before you picked up the habit.
What You Are Actually Inhaling
E-cigarette aerosol is not water vapor, despite the lingering myth. When the liquid heats up, it produces a cocktail of propylene glycol, vegetable glycerin, nicotine (usually), flavoring chemicals, and a range of byproducts created by the heating process itself. Among the most studied are formaldehyde, acetaldehyde, and acrolein, all of which are classified as toxic or carcinogenic. A risk assessment that compiled data across the literature found mean values of about 0.86 micrograms of formaldehyde per puff, 0.67 micrograms of acetaldehyde per puff, and 0.37 micrograms of acrolein per puff, with maximum formaldehyde levels reaching as high as 28 micrograms per puff under certain conditions. The same analysis found trace amounts of heavy metals including arsenic, cadmium, lead, and chromium, with inhalation posing a higher overall health risk than dermal or oral contact with e-liquid.
Those numbers need context. At normal operating voltage, daily formaldehyde exposure from vaping can be about a third lower than from smoking 20 cigarettes. But crank the voltage up and the picture reverses dramatically. One replication study found that formaldehyde emissions jumped from about 3.4 micrograms per 10 puffs at low voltage to over 700 micrograms per 10 puffs at the highest setting tested, a roughly 200-fold increase. The researchers confirmed that those extreme conditions produce a harsh, unpleasant experience that most users would avoid, but the finding underscores an important point: the device settings and how you use them change the risk profile enormously.
Your Device Settings Change Everything
This is one of the least appreciated aspects of vaping safety. The same liquid in the same device can produce wildly different exposures depending on coil temperature, puff duration, and power output. Carbonyl emissions, the category that includes formaldehyde and acrolein, increase almost linearly with longer puffs and rise sharply at higher coil temperatures. Increasing the proportion of vegetable glycerin in the liquid tends to reduce most carbonyls but actually increases acrolein, a particularly irritating compound. These trade-offs make blanket statements about “how much” of a given chemical you inhale from vaping nearly meaningless without specifying the hardware and habits involved.
Disposable e-cigarettes, which dominate the youth market, bring their own problems. A chemical analysis of popular disposable devices found that 89% of the liquids tested contained ethyl maltol, a sweetener and flavor enhancer, with 42% of those showing concentrations more than 10 times the limits set by food-additive standards. Even more concerning, 88% exceeded concentrations previously reported as toxic to cells. Nearly nine out of ten devices also contained benzoic acid at levels that exceeded the threshold linked to DNA damage in human cells by more than 20-fold. Both chemicals showed a pattern of increasing concentration as the device was used, meaning the last puffs from a disposable may be more toxic than the first.
What Happens to Your Lungs
The respiratory system takes the first and most direct hit. A systematic review of studies on lung function in e-cigarette users found that vaping increases airway resistance, meaning the small airways narrow slightly and it becomes a bit harder for air to flow freely. However, the standard measures of overall lung capacity that doctors check in a breathing test did not appear to change in the short-term studies available. The review’s authors were careful to note that the studies were small and short, so longer-term consequences remain an open question.
Beyond the mechanical effects on airflow, vaping appears to compromise your lungs’ ability to fight infection. Animal studies have shown that mice exposed to e-cigarette vapor and then infected with pneumonia-causing bacteria had significantly more bacteria in their lungs because their immune cells were worse at engulfing and destroying the invaders. When exposed to influenza and e-cigarette vapor together, mice had higher viral loads, took longer to recover, lost more weight, and died at higher rates than mice that were infected but had not been exposed to vapor. These are animal findings, so they do not translate directly to humans, but the mechanism, impaired immune-cell function in the lungs, is consistent with what clinicians have observed in vapers who get respiratory infections.
E-cigarette vapor can also induce DNA strand breaks in cells, including dangerous double-strand breaks that are especially likely to cause permanent mutations. Lab studies found that even nicotine-free vapor increased DNA damage compared to untreated cells, with nicotine-containing vapor compounding the effect further. Vapor promoted the formation of DNA adducts and drove oxidative stress and inflammatory signaling in exposed cells. Whether this translates to meaningful cancer risk in humans over decades of use is one of the biggest unanswered questions in the field, but the cellular-level findings are not reassuring.
The EVALI Scare and What It Actually Taught Us
In the summer of 2019, a wave of severe lung injuries swept through the United States, alarming the public and generating headlines that made vaping sound immediately lethal. The condition was named EVALI, for e-cigarette or vaping product use-associated lung injury. Patients, most of them young, showed up with cough, shortness of breath, fever, and chest imaging that looked like pneumonia or chemical injury. Investigators eventually identified vitamin E acetate, a thickening agent used in illicit THC cartridges, as the likely culprit. In a key study, vitamin E acetate was found in the lung fluid of 48 out of 51 EVALI patients across 16 states but was absent from healthy comparison subjects. Among those patients, 94% had detectable THC or its metabolites, or reported vaping THC products in the 90 days before getting sick.
The EVALI outbreak taught two lessons that are often conflated. First, black-market and counterfeit vaping products can be acutely dangerous in ways that regulated nicotine products are not. Second, the episode revealed how little oversight exists over what actually goes into vaping devices, particularly disposable ones sold outside regulated channels. EVALI was not primarily a story about nicotine vaping, but it exposed the broader risks of an industry where quality control ranges from strict to nonexistent depending on the product.
Flavors Are Not Just a Marketing Concern
The debate over flavored e-cigarettes usually focuses on their appeal to teenagers, but there is a separate and underappreciated toxicity question. A systematic review of pulmonary effects found that mint and menthol flavors were the most frequently reported to cause harmful effects in lab studies, followed by cinnamon and strawberry. These flavors showed damage across multiple types of tests, including cell death, reduced metabolic activity, and markers of inflammation.
Menthol stands out as particularly aggressive. In one study exposing human lung cells to e-liquids, menthol flavoring killed 45% of cells after just two hours at a low concentration. By 48 hours, more than 80% of cells were dead even at the lowest concentration tested. Under the microscope, the cells had rounded up and detached from the surface, a hallmark of severe toxicity. Flavoring compounds that are considered safe to eat are not necessarily safe to inhale, because the lungs lack the detoxification machinery of the digestive tract. This disconnect between food-grade safety and inhalation safety is one of the largest regulatory blind spots in the vaping industry.
Your Heart and Blood Vessels
Vaping’s cardiovascular effects have become clearer over the past few years, and the news is not great. A study comparing chronic e-cigarette users, smokers, and non-users found that both vapers and smokers had lower flow-mediated dilation, a measure of how well blood vessels relax in response to increased blood flow. That impairment is a well-established early warning sign of cardiovascular disease. Blood from vapers also reduced the ability of blood vessel lining cells to produce nitric oxide, the molecule that keeps vessels flexible and open. Intriguingly, vaping caused a specific effect that smoking did not: it increased the permeability of small blood vessels, meaning the lining became leakier. The researchers suggested this may represent a vaping-specific mechanism of vascular harm distinct from what cigarettes do.
A separate meta-analysis looking at arterial stiffness found that exclusive e-cigarette use had a similar impact on one key stiffness marker as exclusive cigarette smoking. That is a sobering finding, because arterial stiffness is linked to heart attack and stroke risk down the line. The cardiovascular research is still catching up, with most studies being cross-sectional snapshots rather than long-term tracking, but the early signals point toward real vascular damage that is not dramatically better than what cigarettes cause, even if the chemical exposure profile is lower.
What Vaping Does to Your Mouth
Your oral cavity is the first tissue the aerosol touches, and it shows. Vapers have elevated levels of inflammatory markers in the fluid around their gums, including signals associated with tissue breakdown and abnormal blood vessel growth. Both vaping and smoking are significantly linked to untreated cavities and other dental disorders, and vapers specifically show a higher likelihood of untreated decay. Flavored e-liquids appear to be worse for oral bacteria than unflavored ones, disrupting the normal microbial community in ways that could promote disease.
A systematic review of the oral microbiome in vapers found consistent shifts in the bacterial communities living under the gumline, with increases in anaerobic species like Treponema denticola and Tannerella forsythia, both of which are associated with periodontal disease. People who both smoke and vape, the so-called dual users, fare worst of all. A population-based study found that dual users had more than three times the odds of gum disease and loose teeth compared with non-users, and higher odds than either exclusive smokers or exclusive vapers alone.
Vaping as a Quit-Smoking Tool
The strongest argument in favor of e-cigarettes has always been their potential to help smokers quit. On this front, the evidence is genuinely positive, if complicated. A landmark randomized trial found that smokers assigned to e-cigarettes had a one-year abstinence rate of 18%, compared with about 10% for those given traditional nicotine replacement like patches or gum. A meta-analysis of randomized controlled trials confirmed the direction of this finding, calculating that nicotine e-cigarettes roughly doubled the odds of achieving verified abstinence compared with other cessation methods. The number needed to treat, meaning how many smokers would need to switch to e-cigarettes for one additional person to quit, was 26.
Those numbers sound promising, and for an individual smoker who has failed with patches or gum, they probably are. But the cessation story gets muddied by how people actually use these products in the real world. Nearly half of e-cigarette users also continue to smoke cigarettes. This dual-use pattern undermines the harm-reduction argument, because dual users are exposed to the toxicants from both products. A large pooled analysis found that dual users had increased odds of multiple health outcomes compared with exclusive smokers, with pooled odds ratios ranging from 1.20 to 1.41 depending on the condition. In other words, adding vaping on top of smoking appears to make things worse, not better. The cessation benefit is real, but only if you actually stop smoking.
How Vaping Compares to Smoking (and to Nothing)
The comparison that matters most depends on who you are. If you are a current smoker, the evidence strongly suggests that switching completely to e-cigarettes reduces your exposure to dozens of harmful chemicals. Exclusive e-cigarette users showed 10% to 98% lower concentrations of cancer-related biomarkers, tobacco-specific compounds, and most volatile organic chemicals compared to exclusive smokers. A nationally representative study went further, finding that for many toxicants, exclusive e-cigarette users did not differ meaningfully from people who used no tobacco products at all, though they still had equivalent nicotine levels.
If you are a non-smoker, that comparison is irrelevant. Your baseline is clean air, and any chemical exposure from vaping is purely additive. The fact that vaping is substantially less harmful than smoking does not make it benign for someone who would otherwise be inhaling nothing. This distinction gets lost in public-health messaging and industry marketing alike, and it is the central tension in the entire vaping debate.
Nicotine Addiction and the Adolescent Brain
Modern e-cigarettes are remarkably efficient nicotine delivery systems. Nicotine salt formulations at high concentrations can produce peak blood nicotine levels of about 12 nanograms per milliliter within just two to two and a half minutes of the last puff. That speed matters, because faster delivery means stronger reinforcement and higher addiction potential.
For adolescents, the addiction risk is compounded by developmental vulnerability. The adolescent brain is still wiring itself, and nicotine exposure during this window has consequences that persist into adulthood. Animal research has shown that adolescent nicotine exposure, but not the same exposure after adolescence, leads to lasting cognitive problems including reduced attention and increased impulsivity. These changes are tied to disrupted signaling in the prefrontal cortex, the brain region responsible for planning and impulse control. Emotional responses are also affected, with increased anxiety and fear documented after adolescent nicotine treatment. A 2024 CDC analysis found that 42% of youth who currently used e-cigarettes reported moderate-to-severe symptoms of depression and anxiety, compared with 21% of youth who had never or formerly used them. Those with worse mental health symptoms were also more likely to show signs of nicotine dependence, like craving a hit within 30 minutes of waking up.
It is worth noting that association is not causation; adolescents with anxiety may be drawn to nicotine as a coping mechanism rather than being made anxious by it. But the animal data showing long-term emotional and cognitive effects of adolescent nicotine are hard to dismiss, and the combination of evidence suggests this is not simply a case of vulnerable kids self-selecting into vaping.
Pregnancy and Fetal Risks
Some pregnant women have turned to e-cigarettes as a perceived safer alternative to smoking during pregnancy. The limited evidence available is not encouraging. In animal models, exposure to e-cigarette emissions during pregnancy led to fetal losses through reabsorption in the uterus and reduced survival of pups during the weaning period compared to controls. Critically, these effects occurred even when the vapor contained no nicotine or flavorings, suggesting that the base solvents or heat-generated byproducts themselves are harmful to fetal development. Maternal vascular function was also impaired, with changes in hormone levels and blood vessel behavior that persisted beyond the exposure period. The researchers suggested that the recovery window for vascular damage in the mother is likely longer than the exposure window itself, meaning the effects linger after you stop vaping.
Effects Beyond the Lungs
The gut is an emerging area of vaping research that most people would not think to ask about. Chronic exposure to nicotine-free e-cigarette aerosol in lab models caused a dramatic collapse in the gut barrier’s integrity, with a roughly 97% drop in the electrical resistance that measures how tightly gut lining cells seal together. That barrier is what keeps bacteria and toxins in your intestinal tract from leaking into your bloodstream. Chronic exposure also upregulated inflammatory genes and reduced the expression of tight junction proteins that hold gut cells together. The findings are preliminary, from cell and animal models rather than human studies, but they open the possibility that vaping could contribute to systemic inflammation through a pathway most people have never considered.
Secondhand Aerosol Exposure
If you do not vape but share indoor space with someone who does, you are still getting an exposure, though it is meaningfully different from secondhand cigarette smoke. E-cigarette use indoors produces fine and ultrafine particle levels comparable to those from tobacco cigarettes, which is a genuine concern since ultrafine particles can penetrate deep into the lungs. However, the chemical concentrations in the aerosol are generally lower, and unlike cigarette smoke, there is no side-stream emission: the only aerosol comes from what the user exhales. A systematic review covering two decades of research found that levels of nicotine, propylene glycol, aldehydes, and heavy metals are documented in secondhand vaping aerosol but are below secondhand smoke levels and in many cases comparable to non-smoking environments without any vaping. That is reassuring relative to cigarettes, but “comparable to non-smoking environments” and “identical to clean air” are not the same thing, and long-term bystander exposure has not been well studied.
Disposable Devices and the Regulation Gap
The shift toward cheap, disposable e-cigarettes has outpaced regulatory enforcement in most countries. These devices are often manufactured overseas with little quality control, and the chemical analysis of their contents is frequently alarming. The finding that most tested disposables contained ethyl maltol and benzoic acid at concentrations far exceeding safety thresholds is not an outlier in the literature; it is consistent with a pattern of additives present at levels never intended for inhalation. The concentrations of both chemicals increased as the device was used, likely because the liquid near the coil becomes more concentrated and thermally degraded as the reservoir empties. If you are using a disposable device, the puffs near the end of its life are probably the most chemically loaded.
Regulation varies wildly by jurisdiction. Some countries have banned flavored products or capped nicotine concentrations. Others have virtually no oversight. The result is a marketplace where a regulated, pharmaceutical-grade nicotine e-cigarette designed for smoking cessation exists alongside illicit THC cartridges cut with vitamin E acetate and cotton-candy-flavored disposables containing untested chemical cocktails. Treating all of these as “vaping” and assigning a single risk level is neither scientifically honest nor particularly useful.